col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Biomolecules
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―18 The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic Maryam Azimzadeh, Nora Möhn, Sajjad Ghane Ezabadi, Zahra Moghimi Esfandabadi, Alireza Soleimani, Elaheh Ranjbar, et al. (+4)
2 [GO] 2021―Sep―17 Further Findings Concerning Endothelial Damage in COVID-19 Patients Monica Gelzo, Sara Cacciapuoti, Biagio Pinchera, Annunziata De Rosa, Gustavo Cernera, Filippo Scialò, et al. (+7)
3 [GO] 2021―Sep―15 Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34 Bathini Thissera, Ahmed M. Sayed, Marwa H. A. Hassan, Sayed F. Abdelwahab, Ngozi Amaeze, Valeria T. Semler, et al. (+5)
4 [GO] 2021―Aug―26 Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency Ahmed L. Alaofi, Mudassar Shahid
5 [GO] 2021―Aug―20 Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant Priya Antony, Ranjit Vijayan
6 [GO] 2021―Aug―17 HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study Gerardo Cazzato, Anna Colagrande, Antonietta Cimmino, Gerolamo Cicco, Vincenza Sara Scarcella, Paola Tarantino, et al. (+10)
7 [GO] 2021―Aug―13 Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women Aleksandra Obuchowska, Arkadiusz Standyło, Karolina Obuchowska, Żaneta Kimber-Trojnar, Bożena Leszczyńska-Gorzelak
8 [GO] 2021―Aug―02 Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study Beata Kuśnierz-Cabala, Barbara Maziarz, Paulina Dumnicka, Marcin Dembiński, Maria Kapusta, Monika Bociąga-Jasik, et al. (+4)
9 [GO] 2021―Jul―30 Relevance of BET Family Proteins in SARS-CoV-2 Infection Nieves Lara-Ureña, Mario García-Domínguez
10 [GO] 2021―Jul―28 Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2 Raquel Arroyo, Shawn N. Grant, Miriam Colombo, Lucia Salvioni, Fabio Corsi, Marta Truffi, et al. (+5)
11 [GO] 2021―Jul―20 Adventitial Microcirculation Is a Major Target of SARS-CoV-2-Mediated Vascular Inflammation Francesco Vasuri, Carmen Ciavarella, Salvatore Collura, Chiara Mascoli, Sabrina Valente, Alessio Degiovanni, et al. (+3)
12 [GO] 2021―Jul―19 Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays Fulvio Perrella, Federico Coppola, Alessio Petrone, Chiara Platella, Daniela Montesarchio, Annarita Stringaro, et al. (+4)
13 [GO] 2021―Jul―13 COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Kenneth Lundstrom, Debmalya Barh, Bruce D. Uhal, Kazuo Takayama, Alaa A. A. Aljabali, Tarek Mohamed Abd El-Aziz, et al. (+20)
14 [GO] 2021―Jul―06 COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies Renuka Raman, Krishna J. Patel, Kishu Ranjan
15 [GO] 2021―Jul―05 Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19 Graham J. Moore, Jose M. Pires, Konstantinos Kelaidonis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, John M. Matsoukas
16 [GO] 2021―Jun―22 Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type Anwar Mohammad, Fahd Al-Mulla, Dong-Qing Wei, Jehad Abubaker
17 [GO] 2021―Jun―18 Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19 Saadullah Khattak, Mohd Ahmar Rauf, Qamar Zaman, Yasir Ali, Shabeen Fatima, Pir Muhammad, et al. (+6)
18 [GO] 2021―Jun―14 Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk Sara Chiappalupi, Laura Salvadori, Rosario Donato, Francesca Riuzzi, Guglielmo Sorci
19 [GO] 2021―Jun―08 Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? Luisa Diomede, Marten Beeg, Alessio Gamba, Oscar Fumagalli, Marco Gobbi, Mario Salmona
20 [GO] 2021―Jun―07 SARS-CoV-2 and Skin: The Pathologist’s Point of View Gerardo Cazzato, Giulia Mazzia, Antonietta Cimmino, Anna Colagrande, Sara Sablone, Teresa Lettini, et al. (+10)
21 [GO] 2021―May―28 Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases Dakshinamurthy Sivakumar, Matthias Stein
22 [GO] 2021―May―26 Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia Francesca Lunardi, Francesco Fortarezza, Luca Vedovelli, Federica Pezzuto, Annalisa Boscolo, Marco Rossato, et al. (+7)
23 [GO] 2021―May―24 Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement Mathew A. Coban, Juliet Morrison, Sushila Maharjan, David Hyram Hernandez Medina, Wanlu Li, Yu Shrike Zhang, et al. (+6)
24 [GO] 2021―May―06 Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps Brandon Bautista-Becerril, Rebeca Campi-Caballero, Samuel Sevilla-Fuentes, Laura M. Hernández-Regino, Alejandro Hanono, Al Flores-Bustamante, et al. (+6)
25 [GO] 2021―Apr―29 Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm Seth O. Asiedu, Samuel K. Kwofie, Emmanuel Broni, Michael D. Wilson
26 [GO] 2021―Apr―27 Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach Marie-Thérèse Hopp, Daniel Domingo-Fernández, Yojana Gadiya, Milena S. Detzel, Regina Graf, Benjamin F. Schmalohr, et al. (+3)
27 [GO] 2021―Apr―20 SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors Andrea Citarella, Angela Scala, Anna Piperno, Nicola Micale
28 [GO] 2021―Apr―20 Protein Intrinsic Disorder and Evolvability of MERS-CoV Vladimir N. Uversky, Elrashdy M. Redwan, Abdullah A. Aljadawi
29 [GO] 2021―Apr―14 Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2 Anwar Mohammad, Eman Alshawaf, Sulaiman K. Marafie, Mohamed Abu-Farha, Fahd Al-Mulla, Jehad Abubaker
30 [GO] 2021―Mar―19 Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) Amr El-Demerdash, Ahmed M. Metwaly, Afnan Hassan, Tarek Mohamed Abd El-Aziz, Eslam B. Elkaeed, Ibrahim H. Eissa, et al. (+2)
31 [GO] 2021―Mar―15 COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020 Francesca Colavita, Francesco Vairo, Silvia Meschi, Maria Beatrice Valli, Eleonora Lalle, Concetta Castilletti, et al. (+9)
32 [GO] 2021―Mar―09 Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks Murat Seyran, Sk. Sarif Hassan, Vladimir N. Uversky, Pabitra Pal Choudhury, Bruce D. Uhal, Kenneth Lundstrom, et al. (+15)
33 [GO] 2021―Mar―08 Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis Eugenio Hardy, Carlos Fernandez-Patron
34 [GO] 2021―Feb―22 Screening and Molecular Modeling Evaluation of Food Peptides to Inhibit Key Targets of COVID-19 Virus Ai-Min Shi, Rui Guo, Qiang Wang, Jin-Rong Zhou
35 [GO] 2021―Feb―18 Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages Umesh Kalathiya, Monikaben Padariya, Robin Fahraeus, Soumyananda Chakraborti, Ted R. Hupp
36 [GO] 2021―Feb―04 In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19 Nadia A. Rivero-Segura, Juan C. Gomez-Verjan
37 [GO] 2021―Jan―31 Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection Hao Sun, Xiaojuan Su, Lingyi Huang, Dezhi Mu, Yi Qu
38 [GO] 2021―Jan―13 Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm Alexandra Pum, Maria Ennemoser, Tiziana Adage, Andreas J. Kungl
39 [GO] 2021―Jan―08 Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies Lúcio Ricardo Leite Diniz, Yunierkis Perez-Castillo, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de Sousa
40 [GO] 2020―Dec―31 Potential Medicinal Plants for the Treatment of Dengue Fever and Severe Acute Respiratory Syndrome-Coronavirus Mohammed S. M. Saleh, Yusof Kamisah
41 [GO] 2020―Dec―28 A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease Alejandro Llanes, Héctor Cruz, Viet D. Nguyen, Oleg V. Larionov, Patricia L. Fernández
42 [GO] 2020―Dec―14 Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs Ainhoa Moliner-Morro, Daniel J. Sheward, Vivien Karl, Laura Perez Vidakovics, Ben Murrell, Gerald M. McInerney, Leo Hanke
43 [GO] 2020―Oct―16 A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool German Todorov, Vladimir N. Uversky
44 [GO] 2020―Sep―21 Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues Ognjen Perišić
45 [GO] 2020―Sep―14 Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics? Fatma Elrashdy, Elrashdy M. Redwan, Vladimir N. Uversky
46 [GO] 2020―Aug―12 Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) Mahir Karakas, Dominik Jarczak, Martin Becker, Kevin Roedl, Marylyn M. Addo, Frauke Hein, et al. (+7)
47 [GO] 2020―Jun―24 Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis Joseph T. Ortega, Maria Luisa Serrano, Beata Jastrzebska
48 [GO] 2020―Mar―02 Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63 Yu-Chi Tsai, Chia-Lin Lee, Hung-Rong Yen, Young-Sheng Chang, Yu-Ping Lin, Su-Hua Huang, Cheng-Wen Lin
49 [GO] 2020―Feb―21 Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.008 sec